CRC Malmö - a modern clinical research centre

Between the world of health care, research, education and business life there has for many been a lack of integration, which possibly has meant that valuable information has not come to the benefit of worldwide health.   

The CRC - Clininical Research Centre   - in Malmö, Sweden is a new project, which unite these areas. 
The CRC has arisen from the vision of integrating health care, research, education under one roof and with close ties to business life. Within health care the relevant queations are asked, research provides the answers, education gives new thoughts and ideas and businesses commercialise the results. As Hugh Connell, Principal at CRC, states it ”CRC leads the areas back together”. 

With this in mind, the CRC is the result of a joint cooperation between the medical faculty of Lund University, the Region of Skåne and the regional health authority. The actual building and operation of the project is the responsibility of the Regional estate authority cooperation with the management of the centre, the university and the region. 

The research

The new Clinical Research Centre offers an attractive research environment right in the centre of Malmö. By providing the best possible facilities, new medical discoveries can be made, diagnostic tools and treatment can be improved, and preventive medicine developed, all contributing to improved health worldwide. 

The actual research at CRC is very broad. Clinical and preclinical researchers work together on studies of common diseases such as cardiovascular diseases, diabetes, obesity, cancer and epidemology. 

A great example of the CRC vision -  to integrate various fields - is the work the newly created diabetes team is to carry out. The 60-persons team includes e.g. physiologists, cardiologists, eye specialist and doctors. Hugh Connell continous: ”You might say that we have moved from research at sub-level to a unified level. We would like to see the whole individual, examine  all the problems.” 

Apart from the diabetes team, other researchers are working at various projects, such as:

  • to develop a vaccine that reduces the risk of having a heart attack or a stroke. Researchers hope that the vaccine will be ready to test on humans within a couple of years.
  • to develop new diagnostic tools and treatment for optimised, individually adapted tumour treatment in patients with localised, advanced prostate cancer.
  • to understand why type 1 diabetes is increasing so rapidly in children. All newborn children in Skåne are taking part in, what is known as, the TEDDY study.
  • to investigate whether a vaccine against a protein called GAD65 can slow down the development of type 1 diabetes, which is an autoimmune disease, using clinical trials.
  • to develop a genetic map regarding type 2 diabetes, which will help identify those at risk of developing the condition. The genetic map can also provide information on how the disease develops and this can be used to develop new pharmaceuticals.
  • to increase knowledge concerning how people with functional disorders can participate in society on equal terms. 

At present, many discoveries have already been conceived and developed in fruitful collaboration with local, national and international companies. The treatment of haemophilia and contrast agents for radiology are two examples of this.

The learning environment

The learning environment is one of a kind. Apart from brand new specially adapted teaching premises the students will have access to learning centres with all necessary equipment. Moreover, students can improve their skills using dummies under simulated operations and other acute conditions.   

The CRC is located in the Öresund Region, which is home to 14 universities, 26 hospitals, 7 science and technology parks and around 42,000 employees. All working to stregthen medical development. 

Switchboards

In relation to the application of switchboards, Pär Erik Stål, project  manager, Regional estete authority, explains that the project consists of one main station and two satellite stations. The entire project is supplied by the company Electrotech, Malmö, and circumvents 277 modules corresponding to 53.4 m. 

The main station consists of two switchboards and is feed by two 2000 kVA transformers with a rated current on 3200A. Additionally, four switchboards have been supplied with a rated current of 1250A. 

Following, the specification, Electrotech has, installed 18 ACB-breakers and 176 outgoing groups in various sizes (100-630A). 

To reduce the electromechanical fields, aluminum has been installed in the switchboard as a special feature. The aluminum covers the entire ceiling and all of the walls. 
All in all an impressive project to the benefit of our health.